Samsung Bioepis
Samsung Bioepis is a South Korea–based biopharmaceutical company focused on making healthcare more accessible through high-quality biosimilars. By developing and commercializing affordable alternatives to biologic drugs, they aim to get life-changing medicines to patients faster and more efficiently.
Led by CEO Christopher Hansung Ko, the company has brought multiple biosimilars to market in just seven years—and is rapidly expanding its pipeline to meet growing global demand.
Bringing these medicines to market requires approved clinical trials in regions around the world. That’s where Interpret Group stepped in.
- Multi-Region Coverage, Seamlessly Managed: Samsung Bioepis needed reliable, on-site consecutive interpreting across five global regions—each with its own medical focus and regulatory requirements.
- Only Medically Qualified Interpreters Would Do: Every interpreter had to meet strict criteria, including advanced medical training and relevant degrees, to ensure clinical accuracy.
- One Partner, One Process: They wanted a single point of contact to manage everything—from scheduling and vetting to cost transparency and invoicing—making a complex project feel simple.
Challenge
Samsung Bioepis needed highly qualified consecutive interpreters to support clinical trials across multiple regions—including Eastern Europe, Russia, Eurasia, and Southeast Asia. But it wasn’t just about language. Each interpreter had to have specific medical credentials and experience in clinical research.
On top of that, Samsung required a centralized, streamlined process—from making interpreter requests to managing costs and payments, so their teams could focus on the trials, not the logistics.
Solution
Interpret Group assigned International Project Manager José to lead the effort, working directly with Samsung’s Clinical Quality Assurance team. José handled every detail—from contract coordination and regional placements to pairing the right interpreters with the right specialties.
We sourced through our vetted network for medically trained interpreters at each location, many holding advanced degrees and experience in clinical trial settings. Assignments included not only consecutive interpreting but also sight translation of sensitive medical documents—delivered accurately and securely.
By managing everything under one roof, we streamlined the entire process, making it fast, easy, and stress-free for Samsung’s team.
“During the audit process, the interpreters were very supportive and were coordinated flawlessly. Also, the interpreters’ experience surpassed our expectations and helped our audit team tremendously.”
Sehyun C.
Clinical Quality Assurance
Results
With confidentiality and clinical accuracy as top priorities, our team ensured every interaction met Samsung Bioepis’ strict security protocols.
The success of this partnership led to something even more meaningful: since 2017, Interpret Group has remained Samsung Bioepis’ trusted language partner—supporting their international operations and helping make medical innovation more accessible around the world.
A global team with the right experience
Whatever your needs are, our team is here for you. We are distributed across four regions, with plentiful knowledge in a variety of industry backgrounds and a wealth of knowledge of the interpreting services market. We believe in:
- DELIVERING language services with a personal touch
- MANAGING complex projects anywhere with ease
- CREATING lifelong partnerships
- DELIVERING language services with a personal touch
- MANAGING complex projects anywhere with ease
- CREATING lifelong partnerships
Ready to Simplify Your Next Multilingual Event?
Our Language Specialists are here to manage your entire project from start to finish. Please send us your language needs and event details for a fast and easy quote. Estimate within 24 hours, no commitment needed.